Header Logo

Connection

GAIL ECKHARDT to Neovascularization, Pathologic

Back to Details
This is a "connection" page, showing publications GAIL ECKHARDT has written about Neovascularization, Pathologic.
GAIL ECKHARDT
Connection Strength
0.027
Neovascularization, Pathologic
  1. Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.